HRT Financial’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

HRT Financial’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16K	Buy	+551	New	+$16.1K	﹤0.01%	3594
2025 Q3	–	Sell	-841	Closed	-$69K	–	3761
2025 Q2	$69K	Buy	841 +316	+60%	+$20.5K	﹤0.01%	2266
2025 Q1	$41K	Buy	+525	New	+$64.6K	﹤0.01%	2253
2024 Q1	–	Sell	-201	Closed	-$23K	–	3177
2023 Q4	$23K	Buy	+201	New	+$31.3K	﹤0.01%	2028
2023 Q2	–	Sell	-206	Closed	-$31K	–	3367
2023 Q1	$31K	Buy	+206	New	+$37K	﹤0.01%	2156
2022 Q2	–	Sell	-18	Closed	-$10K	–	3814
2022 Q1	$10K	Buy	+18	New	+$10.7K	﹤0.01%	2899
2021 Q4	–	Sell	-87	Closed	-$108K	–	4177
2021 Q3	$108K	Sell	87 -29	-25%	-$56.2K	﹤0.01%	2879
2021 Q2	$366K	Buy	+116	New	+$459K	﹤0.01%	2019
2021 Q1	–	Sell	-3	Closed	-$15K	–	3203
2020 Q4	$15K	Buy	+3	New	+$18.9K	﹤0.01%	1751

Other funds holding YARW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $134M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HRT Financial's YARW Position: Q1 2026 in Review

HRT Financial opened a new position in Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2026: 551 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #3594 among its holdings. This is a return to the name: HRT Financial previously reported a position in YARW as recently as Q2 2025.

HRT Financial first reported a position in YARW in Q4 2020 and has held it in 9 quarters since. The position peaked at $366K in Q2 2021. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

HRT Financial held 551 shares of Yarrow Bioscience, Inc. Common Stock worth $16K as of Q1 2026.
Yarrow Bioscience, Inc. Common Stock was a new HRT Financial position in Q1 2026.
Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3594 holding.
HRT Financial first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2020 and has held it in 9 quarters since.
HRT Financial's Yarrow Bioscience, Inc. Common Stock position peaked at $366K in Q2 2021.
42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.